Thursday, July 31, 2014

SGX Singapore Opening Market Update : Epic Research Singapore

MARKET UPDATES :

RESEARCHERS from the Singapore General Hospital and the Duke-NUS Graduate Medical School are a step closer to finding a treatment for dengue fever, which currently cannot be treated with an antiviral drug or vaccinated against. The progress comes after the researchers found that Celgosivir, a medicine derived from the seeds of the Moreton Bay Chestnut trees, to be safe for dengue patients.


STOCK RECOMMENDATION :
BUY DBS GROUP HOLDING ABOVE 18.090 TG 18.190, 18.300, 18.440 SL 17.950

Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg

0 comments:

Post a Comment